Grifols, S.A.
GRFS
$7.81
-$0.16-2.01%
NASDAQ
Rating
Reward
Risk
Rating Factors
Growth Index
Efficiency Index
Solvency Index
Total Return Index
Volatility Index
Dividend Yield Index
Headlines
3/12/2026
-
Seeking Alpha - Long Ideas
3/12/2026
-
Seeking Alpha - Healthcare
3/12/2026
-
SeekingAlpha
3/11/2026
-
New York Times - World
3/11/2026
-
Tickeron - Stocks
3/11/2026
-
Tickeron - Stocks
3/10/2026
-
TipRanks Financial Blog
3/10/2026
-
TipRanks Financial Blog
3/10/2026
-
The Fly
3/10/2026
-
Tickeron - Stocks
3/5/2026
-
MarketBeat
3/4/2026
-
Tickeron - Stocks
3/2/2026
-
MarketBeat
2/28/2026
-
Nasdaq News: Stocks
2/27/2026
-
Zero Hedge
2/26/2026
-
TipRanks Financial Blog
2/26/2026
-
SeekingAlpha
2/26/2026
-
Seeking Alpha: Transcripts
2/26/2026
-
TipRanks Financial Blog
2/26/2026
-
TipRanks Financial Blog
2/26/2026
-
TipRanks Financial Blog
2/26/2026
-
The Fly
2/26/2026
-
The Fly
2/24/2026
-
Tickeron - Stocks
2/19/2026
-
Tickeron - Technical Analysis
Income Statement
Total Revenue (TTM)
--
EBITDA (TTM)
--
EBIT (TTM)
--
Net Income (TTM)
--
Balance Sheet
Total Assets (Q)
Total Debt (Q)
Total Liabilities (Q)
Book Value Per Share (Q)
Cash Flow
Cash from Operations (TTM)
--
Cash from Investing (TTM)
--
Cash from Financing (TTM)
--
Net Change in Cash (TTM)
--
Filings
Filing Date
Thursday, February 26, 2026
Period Date
Wednesday, December 31, 2025
Next Filing
Week of May 11 and 15 (est)
Price History
Beta
7-Day Total Return
30-Day Total Return
60-Day Total Return
90-Day Total Return
Year to Date Total Return
1-Year Total Return
2-Year Total Return
3-Year Total Return
5-Year Total Return
52-week Low
52-week High
Valuation
Enterprise Value
Price/Sales (TTM)
Price/Book (Q)
Dividends and Shares
Shares Outstanding
Dividend Per Share (Most Recent)
Dividend Per Share (TTM)
Corporate Info
Website
Phone Number
34 935 71 22 00
Address
Parque Empresarial Can Sant Joan
Avinguda de la Generalitat, 152-158 - Sant Cugat del Valles
Barcelona, 08174
Avinguda de la Generalitat, 152-158 - Sant Cugat del Valles
Barcelona, 08174
Country
Year Founded
Business Description
Sector
--
Industry
--
Grifols, S.A., together with its subsidiaries, engages in the research, development, production, and marketing of plasma-derived medicines in the United States, Canada, Spain, Europe, and...
more